Please login to the form below

Not currently logged in
Email:
Password:

HTA bodies

This page shows the latest HTA bodies news and features for those working in and with pharma, biotech and healthcare.

UK’s NICE to revamp its processes to make access to medicines “fairer”

UK’s NICE to revamp its processes to make access to medicines “fairer”

Started by one man with a borrowed laptop, NICE has since grown into one of the world’s leading evidence-based HTA bodies. ... The ABPI will seek “early and better engagement” with companies as part of NICE’s HTA appraisals, said Catchpole, but

Latest news

  • Nature's way Nature's way

    Not to belittle recent advances or the brilliance of my colleagues in that area, but health technology assessment (HTA) is both harder and more difficult than drug or device safety assessment ... But our health economic capabilities are not there yet. If

  • NICE International relaunches, will offer advisory services NICE International relaunches, will offer advisory services

    NICE has become one of the world’s most prominent and well-know health technology assessment (HTA) bodies since its inception in 1999. ... NICE International will build on the expertise of those within the organisation and draw on links with academic

  • Ursula von der Leyen nominated for EU President role Ursula von der Leyen nominated for EU President role

    Among other issues it highlighted was the question of better co-ordination of advice between regulatory authorities and HTA bodies. ... EFPIA yesterday called for a ‘refreshed approach’ to the plans, including ensuring that HTA and reimbursement

  • Lynparza set for further expansion with EU approval in breast cancer Lynparza set for further expansion with EU approval in breast cancer

    The data looks like a significant step forward in treatment, but remains relatively modest, and without overall survival data it is likely to face resistance from HTA bodies such as

  • NICE and Canadian counterpart to offer joint advice service NICE and Canadian counterpart to offer joint advice service

    The two HTA agencies have many methodologies in common, which prompted the launch of the initiative. ... Michelle Mujoomdar (pictured below), Acting Vice President, Evidence Standards, CADTH said: “This exciting new international collaboration between

More from news
Approximately 1 fully matching, plus 40 partially matching documents found.

Latest Intelligence

  • Market shaping demands behaviour change Market shaping demands behaviour change

    In fact, a 2019 study conducted by the German HTA organisation IQWiG concluded that they deem two-thirds of new innovations reaching the market today offer limited or no additional value ... It is now used extensively in policy and healthcare, with

  • Market shaping for better healthcare decisions Market shaping for better healthcare decisions

    In addition, many global HTA bodies are at capacity with the reviews they are being commissioned to undertake, making an expensive, involved and long process even lengthier.

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    The access landscape is further complicated because many health technology assessment (HTA) methodologies are currently not geared up to evaluate these treatments. ... Yet NICE and many other HTA bodies limit their assessment to the cost-effectiveness of

  • It started with a miss It started with a miss

    Similarly, commercial teams need to drill down and understand HTA requirements within the disease category to ensure trials are designed to capture the necessary data for modelling. ... When drugs don’t receive HTA regulatory support in major markets,

  • Integrating patient reported outcomes into clinical trials Integrating patient reported outcomes into clinical trials

    That disconnect is evident in drug reviews published by health technology assessment (HTA) bodies, such as the United Kingdom’s National Institute for Health and Care Excellence (NICE). ... HTA bodies are grappling with some of these limitations

More from intelligence
Approximately 0 fully matching, plus 28 partially matching documents found.

Latest from PMHub

  • Market Shaping for Better Healthcare Decisions

    In addition, many global HTA bodies are at capacity with the reviews they are being commissioned to undertake, making an expensive, involved and long process even lengthier.

  • Real-world evidence: breaking boundaries in rare disease

    patients. When it comes to rare disease, you need real-world evidence.”. However, we are just starting to understand the power of RWE and many stakeholders, including payers, HTA bodies and

  • Plugging knowledge gaps to demonstrate the benefits of new medicines

    The use of consensus techniques was determined by searching appraisal documents and web sites of UK-based HTA bodies. ... The use of consensus techniques was reported in nine technology appraisals from the three different UK HTA bodies, with numbers

  • Value of Medicines

    David Coleiro, Paula Lashley and John Grime take a look at how society values medicines, the role of health technology assessment (HTA) bodies like NICE, what value means when it comes

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...